These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 3261349)

  • 1. The protective efficacy of Haemophilus b polysaccharide vaccine.
    Shapiro ED; Murphy TV; Wald ER; Brady CA
    JAMA; 1988 Sep; 260(10):1419-22. PubMed ID: 3261349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of efficacy of Haemophilus b polysaccharide vaccine in Minnesota.
    Osterholm MT; Rambeck JH; White KE; Jacobs JL; Pierson LM; Neaton JD; Hedberg CW; MacDonald KL; Granoff DM
    JAMA; 1988 Sep; 260(10):1423-8. PubMed ID: 3261350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemophilus influenzae type b polysaccharide vaccine: an efficacy study. Haemophilus Vaccine Efficacy Study Group.
    Harrison LH; Broome CV; Hightower AW
    Pediatrics; 1989 Aug; 84(2):255-61. PubMed ID: 2787496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective efficacy of Haemophilus influenzae type b polysaccharide and conjugate vaccines in children 18 months of age and older.
    Greenberg DP; Vadheim CM; Bordenave N; Ziontz L; Christenson P; Waterman SH; Ward JI
    JAMA; 1991 Feb; 265(8):987-92. PubMed ID: 1992212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective efficacy of Haemophilus influenzae type b polysaccharide vaccine.
    Shapiro ED; Berg AT
    Pediatrics; 1990 Apr; 85(4 Pt 2):643-7. PubMed ID: 2179854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A day care-based study of the efficacy of Haemophilus b polysaccharide vaccine.
    Harrison LH; Broome CV; Hightower AW; Hoppe CC; Makintubee S; Sitze SL; Taylor JA; Gaventa S; Wenger JD; Facklam RR
    JAMA; 1988 Sep; 260(10):1413-8. PubMed ID: 3261348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate): immunogenicity and safety at various doses.
    Yogev R; Arditi M; Chadwick EG; Amer MD; Sroka PA
    Pediatrics; 1990 Apr; 85(4 Pt 2):690-3. PubMed ID: 2107520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex.
    Santosham M; Wolff M; Reid R; Hohenboken M; Bateman M; Goepp J; Cortese M; Sack D; Hill J; Newcomer W
    N Engl J Med; 1991 Jun; 324(25):1767-72. PubMed ID: 1903846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of Haemophilus influenzae type b polysaccharide vaccine.
    Granoff DM; Osterholm MT
    Pediatrics; 1987 Oct; 80(4):590-2. PubMed ID: 3498928
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA workshop on Haemophilus b polysaccharide vaccine--a preliminary report.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1987 Aug; 36(32):529-31. PubMed ID: 3112543
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of Haemophilus b polysaccharide vaccine: an enigma.
    Mortimer EA
    JAMA; 1988 Sep; 260(10):1454-5. PubMed ID: 3261352
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment.
    Cochi SL; Broome CV; Hightower AW
    JAMA; 1985 Jan; 253(4):521-9. PubMed ID: 3918181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, prospective field trial of a conjugate vaccine in the protection of infants and young children against invasive Haemophilus influenzae type b disease.
    Eskola J; Käyhty H; Takala AK; Peltola H; Rönnberg PR; Kela E; Pekkanen E; McVerry PH; Mäkelä PH
    N Engl J Med; 1990 Nov; 323(20):1381-7. PubMed ID: 2233904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expert panel convened by FDA recommends Haemophilus influenzae type B vaccine should continue in use for children older than 2 years.
    Marwick C
    JAMA; 1987 Jun; 257(23):3182-3. PubMed ID: 3495673
    [No Abstract]   [Full Text] [Related]  

  • 15. Progress in Haemophilus type b polysaccharide vaccine use in the United States.
    Cochi SL; O'Mara D; Preblud SR
    Pediatrics; 1988 Jan; 81(1):166-8. PubMed ID: 3257297
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine in infancy.
    Eskola J; Peltola H; Takala AK; Käyhty H; Hakulinen M; Karanko V; Kela E; Rekola P; Rönnberg PR; Samuelson JS
    N Engl J Med; 1987 Sep; 317(12):717-22. PubMed ID: 3306379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemophilus influenzae type b polysaccharide vaccine in New Haven, Connecticut.
    Lichtman J; Shapiro ED; Petersen L; Hadler J
    Pediatrics; 1987 Aug; 80(2):288-9. PubMed ID: 3615100
    [No Abstract]   [Full Text] [Related]  

  • 18. Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination.
    Murphy TV; White KE; Pastor P; Gabriel L; Medley F; Granoff DM; Osterholm MT
    JAMA; 1993 Jan; 269(2):246-8. PubMed ID: 8417244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statement on Haemophilus influenzae type b polysaccharide vaccine.
    CMAJ; 1986 Jun; 134(12):1375-6. PubMed ID: 3486707
    [No Abstract]   [Full Text] [Related]  

  • 20. Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Apr; 34(15):201-5. PubMed ID: 3920487
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.